Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 8, 2025 • 11:00 AM ET

Date/Time Source News Release
05/05/2025 08:00 AM EDT GlobeNewswire Can-Fite Has Raised $175 Million in Total to Date for the Development of Namodenoson and Piclidenoson, Advancing into Pivotal Phase 3 Trials in Liver Cancer and Psoriasis
04/17/2025 08:55 AM EDT GlobeNewswire Following FDA Compassionate Use Approval for Pancreatic Carcinoma with Can-Fite's Namodenoson, Leading U.S. Medical Centers Seek Authorization for their Patients
04/14/2025 02:28 PM EDT GlobeNewswire Can-Fite Announces $3.0 Million Registered Direct Offering of American Depositary Shares
04/14/2025 08:30 AM EDT GlobeNewswire Can-Fite to Generate $685M in Projected Future Revenues from its Partnerships
04/14/2025 08:00 AM EDT GlobeNewswire Can-Fite Reports 2024 Financial Results and Clinical Update
03/24/2025 09:00 AM EDT GlobeNewswire Can-Fite Initiates Pivotal Phase 3 Psoriasis Study of its Oral Drug Piclidenoson with FDA & EMA-Approved Protocol
03/20/2025 09:45 AM EDT GlobeNewswire Can-Fite Partner Vetbiolix Accelerate Piclidenoson Development with Advanced Clinical Trial for Canine Osteoarthritis in a $3.8 Billion Market
03/19/2025 09:00 AM EDT GlobeNewswire Can-Fite to Initiate Phase II Study in the Rare Genetic Disease Lowe Syndrome with Piclidenoson
03/18/2025 08:30 AM EDT GlobeNewswire Can-Fite: FDA Approved Compassionate Use Treatment with Namodenoson in a Pancreatic Cancer Patient
03/03/2025 06:00 AM EST GlobeNewswire Can-Fite Innovative Publication: Namodenoson in Liver Cancer Treatment Alongside with Cardiac, Liver, and Neurological Benefits
Page

Additional News

As of June 8, 2025 • 11:00 AM ET

Date/Time Source News Release
04/14/2025 08:35 AM EDT SeekingAlpha Can-Fite Biopharma GAAP EPS of $0.00, revenue of $0.67M
01/27/2025 09:49 AM EST Baystreet Can-Fite Wins Patent, Shares Flat
01/18/2025 11:00 AM EST SeekingAlpha Netflix, Procter & Gamble, Johnson & Johnson Report Results In Holiday-Shortened Week
01/17/2025 03:00 PM EST SeekingAlpha Catalyst Watch: Netflix earnings, Monster Beverage event, drug data, and quantum volatility
01/09/2025 12:00 PM EST Zacks CanFite Biopharma (CANF) Upgraded to Strong Buy: Here's What You Should Know
12/09/2024 09:55 AM EST Zacks Bears are Losing Control Over CanFite Biopharma (CANF), Here's Why It's a 'Buy' Now
10/09/2024 03:22 PM EDT SeekingAlpha Can-Fite stock rallies 17% on FDA orphan drug designation
09/24/2024 07:49 AM EDT SeekingAlpha Can-Fite gains after agreement for animal arthritis drug
08/30/2024 05:12 PM EDT SeekingAlpha Can-Fite BioPharma files to sell 1.77B shares of common stock for holders
08/29/2024 12:37 PM EDT SeekingAlpha Can-Fite Biopharma GAAP EPS of $0.00, revenue of $0.32M
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.